-
Labour rival eyes win in poll key to UK PM's fate
-
Haiti's World Cup return lifts community in New York
-
McIlroy grabs early lead at fog-hit US Open
-
Trump's Iran deal sparks anger among Republican hawks
-
Swiss heading towards referendum on new nuclear plants
-
Grand Theft Auto VI presales to begin next week
-
Novelist Kundera and wife buried in Czech home city
-
Hegseth blasts NATO allies, says US will review forces in Europe
-
Cuban economy needs 'urgent changes' to overcome crisis: president
-
Greenland sees wildfires earlier in the year
-
US Open resumes after two-hour fog delay
-
The vaccines and treatments being developed for Ebola outbreak
-
Spanish king to visit Mexican president on June 25 as ties improve
-
Ton-up Phillips stars for New Zealand against England
-
Wahi denied Canadian visa for Ivory Coast World Cup clash with Germany
-
Swiss central bank holds interest rates, with eye on currency risks
-
S.African sentenced in 'world's largest' rhino trafficking case
-
Bank of England follows Fed in holding interest rate
-
Bittersweet World Cup for Gaza's football fans
-
Trump defends Iran deal from critics he calls 'fools'
-
New heatwave disrupts trains, schools in France
-
German chemical company to cut 3,200 jobs as crisis worsens
-
Starmer's Labour rival eyes win in UK poll key to PM's fate
-
Oil falls further on Mideast deal, but Fed outlook knocks equities
-
Mexico, Korea eye World Cup knockout berths
-
Range raises $8.3M Series A to unify treasury, risk and compliance across stablecoins and fiat
-
IAEA ready to help define 'concrete steps' to implement US-Iran deal
-
Ibrahima Konate signs four-year deal with Real Madrid
-
Hegseth tells NATO US will review force presence in Europe
-
Innovations on show at Paris Vivatech fest
-
Ukraine sets Moscow refinery ablaze in biggest attack in years
-
Bird flu kills 13,000 seal pups on remote Australian island
-
Oil prices sink further as Trump signs deal to reopen Hormuz
-
South Korean lawmakers launch probe into ballot paper shortages
-
Starmer rival seeks win in UK poll pivotal to PM's fate
-
Taiwan president says hopes for $14 bn US arms sale 'as soon as possible'
-
Why are Kenyan kids burning schools and killing their classmates?
-
New wave of anti-LGBTQ laws sweeps Africa
-
Ukraine hopes renewables can Russia-proof power grid
-
Jubilant New York on guard for Knicks parade
-
What we learned after the first round of World Cup games
-
New Zealander Manu has 'no fear' of Toulouse before Top 14 semi
-
Drastic restrictions on public transport take effect in Cuba
-
Pain-riddled South Korean man fights for right to die
-
Cuba approves economic reforms to boost private sector, investment: state TV
-
India learns to live with hotter summers
-
'Retired' Wallaby Slipper, 37, set for shock international comeback
-
EU wrestles over how to tackle China export flood
-
Tartan Army takes over Boston as Scotland fans relish World Cup return
-
Comedian Jordan Klepper wishes satire was harder in age of Trump
Animal testing put to the test in Swiss vote
Switzerland goes to the polls Sunday to decide whether animal and human testing should be banned -- a proposal that has triggered an outcry in a country heavily reliant on big pharma.
Opinions suggest that the proposal by animal rights defenders is highly unlikely to pass.
But if it did, "Switzerland would be the only country internationally with such a ban," said Yves Fluckiger, president of the Swiss universities lobby group.
Researchers insist that medical progress is impossible without experimentation.
At the University of Geneva, Patrycja Nowak-Sliwinska, head of the molecular pharmacology laboratory, unveils her cell incubator where intestinal organoids from cancer patients are being cultivated.
These structures, made up of cells, make it possible to test a large number of potential treatments.
"With the in vitro model, we try to find promising candidates" -- and only the latter would then be tested on animals, said Nowak-Sliwinska, who received a prize rewarding researchers who work to replace animals with other methods.
But even she said it would be impossible to do all the research without animal experimentation and clinical trials.
This is why the university's Faculty of Medicine has an animal facility in the basement housing some 25,000 animals -- mostly mice and rats.
- Strict protocols -
Inside, Professor Doron Merkler conducts research to find a treatment for a form of multiple sclerosis.
The research could not advance without using mice, into which he injects modified cells to observe how the disease affects the nervous system.
The mouse he is working on is showing symptoms: instability, difficulty moving, and partial paralysis of the limbs.
The experiments are framed by a strict protocol regarding their degree of severity, and animal keepers are trained to detect when an animal is not well.
"If no veterinary care can be provided to the animal, we can decide with the researcher to sacrifice it," said Pierre Bonnaventure, head of animal facilities at the faculty.
In Switzerland, researchers seeking to use live animals must make a formal request, establish that there is no alternative method available and that the conditions imposed on the animals will be as light as possible.
The number of animals used has consequently fallen sharply, from nearly two million per year in the early 1980s to around 560,000.
Some 20,000 animals a year undergo severe interventions, such as the implantation of a tumour, according to federal authorities.
- Proposal 'goes too far' -
Under Switzerland's direct democracy system, campaigners collected enough signatures to trigger a popular vote.
The proposal would outlaw experiments not only on animals but on humans too, as well as ban the importation of new drugs developed through such means.
"Animal experiments should be considered a crime," Renato Werndli, a doctor among those who launched the initiative, told AFP.
All the major political parties in Switzerland are against the proposal.
For the government, the ban "goes too far" and would have "serious consequences for health" -- and also for the economy, in a country where the chemical and pharmaceutical sector represents just over half of all exports.
Interpharma, the Swiss pharmaceutical industry's lobby group, warned that in the event of a ban, "the institutions and companies concerned would be forced to relocate their activities abroad".
Switzerland has already rejected three initiatives on the subject -- in 1985 (70 percent), 1992 (56 percent) and 1993 (72 percent) -- and is expected to do likewise this time.
But it remains to be seen whether the majority will be as big, in a society where animal welfare has grown in importance.
For Samia Hurst, a bioethicist at the University of Geneva, the new initiative commits "a fairly frequent mistake, which is to target biomedical research".
However, she told AFP: "Animal experimentation, among the various uses that humanity makes of other species, is both the most closely monitored and undoubtedly the most justified."
F.Müller--BTB